Clinical Trial Update: C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Cinryze (C1-esterase inhibitor) for acute treatment of an exacerbation in neuromyelitis optica. The study completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica

Drugs mentioned

• Cinryze (C1 esterase inhibitor)

Snippet

Sponsor: Michael Levy | Conditions: Neuromyelitis Optica | Phase 1 | Status: COMPLETED | Results posted: 2014-07-18